Search - tctmd.com

Displaying 141 - 160 of 269

Sort: Relevancy | Date

News Industry News

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

May 27, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Yael L. Maxwell

May 20, 2014

News Industry News

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

May 15, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

L.A. McKeown

February 17, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Industry News

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

October 30, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

News Industry News

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

October 22, 2013

News Industry News

STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at TCT Conference

October 21, 2013

News Daily News

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Jason Kahn

September 27, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

Advertisement

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

APPOSITION IV: Self-Expanding SES Covers Struts Better, Faster than Balloon-Expandable DES

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

Stent Malapposition Frequent, But Without Clinical Consequences

Second-Generation DES the Better Choice for STEMI Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

MiStent SES Shown to be Unique in Clinical Setting

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing® Stent at TCT Conference

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content